COVID-19 complicated by pulmonary embolism treated with catheter directed thrombectomy

COVID-19 complicated by pulmonary embolism treated with catheter directed thrombectomy

COVID-19 is a recently identified illness that is associated with thromboembolic events. We report a case of pulmonary embolism in a patient with COVID-19, treated by catheter directed thrombectomy. A 57 year old patient presented to the emergency center with severe COVID-19 symptoms and developed m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:VASA 2020-06, Vol.49 (4), p.333-337
Hauptverfasser: Galastri, Francisco Leonardo, Valle, Leonardo Guedes Moreira, Affonso, Breno Boueri, Silva, Marcela Juliano, Garcia, Rodrigo Gobbo, Junior, Milton Rodrigues, Ferraz, Leonardo Jose Rolim, de Matos, Gustavo Faissol Janot, de la Cruz Scarin, Farah Christina, Nasser, Felipe
Format: Artikel
Sprache:eng
Schlagworte:
Betacoronavirus
Coronavirus Infections - complications
Coronavirus Infections - therapy
COVID-19
Fibrinolytic Agents
Humans
Middle Aged
Pandemics
Pneumonia, Viral - complications
Pneumonia, Viral - therapy
Pulmonary Embolism - surgery
Pulmonary Embolism - virology
SARS-CoV-2
Thrombectomy
Treatment Outcome
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:COVID-19 is a recently identified illness that is associated with thromboembolic events. We report a case of pulmonary embolism in a patient with COVID-19, treated by catheter directed thrombectomy. A 57 year old patient presented to the emergency center with severe COVID-19 symptoms and developed massive pulmonary embolism. The patient was treated with catheter directed thrombolysis (CDT) and recovered completely. Coagulopathy associated with COVID-19 is present in all severe cases and is a dynamic process. We describe a case of massive/high risk pulmonary embolism, in a patient with COVID-19 receiving full anticoagulation, who was treated by percutaneous intervention. CDT can be an additional therapeutic option in patients with COVID-19 and pulmonary embolism that present with rapid clinical collapse.
ISSN:0301-1526
1664-2872
DOI:10.1024/0301-1526/a000880